Browsing by Author Gil Gil, Miguel
Showing results 1 to 20 of 38
next >
| Issue Date | Title | Author(s) |
|---|---|---|
| 9-Jun-2020 | A Phase II Prospective, Randomized, Double‐Blind , Placebo‐Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor–Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting | Sánchez Rovira, Pedro; Lindén Hirschberg, Angelica; Gil Gil, Miguel; Bermejo de las Heras, Begoña; Nieto Magro, Concepción |
| 25-Jul-2023 | Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients | Pascual, Javier; Gil Gil, Miguel; Proszek, Paula; Zielinski, Christoph; Reay, Alistair; Ruíz Borrego, Manuel; Cutts, Rosalind; Ciruelos, Eva; Feber, Andrew; Muñoz Mateu, Montserrat; Swift, Claire; Bermejo, Begoña; Herranz, Jesús; Margelí Vila, Mireia; Antón, Antonio; Kahan, Zsuzsanna; Csöszi, Tibor; Liu, Yuan; Fernández García, Daniel; García Murillas, Isaac; Hubank, Michael; Turner, Nicholas C.; Martín, Miguel |
| 1-Nov-2018 | Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04) | Coleman, Robert E.; Collinson, M.; Gregory, W.; Marshall, Helen; Bell, Richard; Dodwell, David; Keane, Maccon; Gil Gil, Miguel; Barrett-Lee, Peter J.; Ritchie, Diana; Bowman, A.; Liversedge, V.; Boer, R. H. de; Passos Coelho, J. L.; O'Reilly, S.; Bertelli, G.; Joffe, J.; Brown, J. E.; Wilson, C.; Tercero, J. C.; Jean Mairet, J.; Gomis, R.; Cameron, David |
| 6-Jun-2013 | Bevacizumab for the treatment of glioblastoma | Gil Gil, Miguel; Mesia Barroso, Carlos; Rey, Montserrat; Bruna, Jordi |
| 13-Oct-2011 | Breast-cancer Adjuvant Therapy With Zoledronic Acid | Coleman, Robert E.; Marshall, Helen; Cameron, David; Dodwell, David; Burkinshaw, Roger; Keane, Maccon; Gil Gil, Miguel; Houston, Stephen J.; Grieve, Robert J.; Barrett-Lee, Peter J.; Ritchie, Diana; Pugh, Julia; Gaunt, Claire; Rea, Una; Peterson, Jennifer; Davies, Claire; Hiley, Victoria; Gregory, Walter; Bell, Richard |
| 14-Apr-2023 | CCNE1 and PLK1 Mediate Resistance to Palbociclib in HR+/HER2−Metastatic Breast Cancer | Guerrero Zotano, Ángel; Belli, Stefania; Zielinski, Christoph; Gil Gil, Miguel; Fernández Serra, Antonio; Ruíz Borrego, Manuel; Ciruelos, Eva; Pascual, Javier; Muñoz Mateu, Montserrat; Bermejo, Begoña; Margeli Vila, Mireia; Antón, Antonio; Murillo, Laura; Nissenbaum, Bella; Liu, Yuan; Herranz, Jesús; Fernández García, Daniel; Caballero, Rosalía; López Guerrero, José Antonio; Bianco, Roberto; Formisano, Luigi; Turner, Nicholas; Martín, Miguel |
| 6-Mar-2024 | Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy | Pascual, Tomás; Fernández Martínez, Aranzazu; Agrawal, Yash; Pfefferle, Adam D.; Chic Ruché, Núria; Brasó Maristany, Fara; Gonzàlez-farré, Blanca; Paré, Laia; Villacampa, Guillermo; Saura, Cristina; Hernando, Cristina; Muñoz, Montserrat; Galván, Patricia; Gonzàlez Farré, Xavier; Oliveira, Mafalda; Gil Gil, Miguel; Ciruelos, Eva; Villagrasa, Patricia; Gavilá, Joaquín; Prat Aparicio, Aleix; Perou, Charles M. |
| 19-Apr-2025 | Comprehensive Clinical Characterization and Long-Term Follow-Up of the Institut Català d’Oncologia Breast Cancer Observational Cohort Study | Pla, Helena; Fullana, Bartomeu; Esteve, Anna; Fort Culillas, Roser; Ferrando Díez, Angelica; Fernández Ortega, Adela; Pous, Anna; Stradella, Agostina; Villanueva Vázquez, Rafael; Cirauqui, Beatriz; Falo Zamora, Catalina; Martínez Pérez, Evelyn; Molina, Guadalupe; Barco, Sonia del; Eraso Urién, Arantxa; Margelí Vila, Mireia; Viñas Vilaró, Gemma; Gil Gil, Miguel; Petriz, Lourdes; Pernas, Sònia |
| 30-Oct-2009 | Critical appraisal of temozolomide formulations in the treatment of primary brain tumors: patient considerations | García Martín, Margarita; Clopés Estela, Ana; Bruna, Jordi; Martínez García, María; Fort Casamartina, Eduard; Gil Gil, Miguel |
| 11-May-2025 | Denosumab as an immune modulator in HER2-negative early breast cancer: results of the window-of-opportunity D-BIOMARK clinical trial | Vethencourt, Andrea; Trinidad Alvarez, Eva Maria; Dorca Duch, Eduard; Petit, Anna; Soler Monsó, M. Teresa; Ciscar, Marina; Barranco, Alexandra; Pérez Chacon, Gema; Jimenez, María; Rodríguez, Mario; Gómez Aleza, Clara; Purqueras, Elvira; Hernández Jiménez, Enrique; Urruticoechea Ribate, Ander; Morilla, Idoia; Subirana Cachinero, Isaac; García Tejedor, María Amparo; Gil Gil, Miguel; Pernas, Sònia; Falo, Catalina; González Suárez, Eva |
| 1-May-2020 | Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial | Lindén Hirschberg, Angelica; Sánchez Rovira, Pedro; Presa Lorite, Jesús; Campos Delgado, Míriam; Gil Gil, Miguel; Lidbrink, Elisabet; Suárez Almarza, Javier; Nieto Magro, Concepción |
| 17-Jun-2025 | Extended follow-up of palbociclib with fulvestrant or letrozole for endocrine-sensitive, hormone receptor-positive/HER2-negative advanced breast cancer in the PARSIFAL trial | Llombart Cussac, Antonio; Pérez García, José Manuel; Bellet Ezquerra, Meritxell; Dalenc, Florence; Gil Gil, Miguel; Ruiz Borrego, Manuel; Gavilá, Joaquín; Schmid, Peter; Zamora, Pilar; Wheatley, Duncan; Martínez de Dueñas, Eduardo; Amillano, Kepa; Di Cosimo, Serena; Antón, Antonio; Cottu, Paul-Henri; Shimizu, Eileen; Fernandez Pinto, Melissa; Sampayo Cordero, Miguel; Cortés, Javier |
| 24-Aug-2016 | Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients | Molina, David; Pérez Beteta, Julián; Martínez González, Alicia; Sepúlveda, Juan M.; Peralta, Sergi; Gil Gil, Miguel; Reynes, Gaspar; Herrero, Ana; Peñas, Ramón de las; Luque, Raquel; Capellades, Jaume; Balaña, Carmen; Pérez García, Víctor M. |
| 1-Oct-2021 | Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor–positive metastatic breast cancer: Patient-reported outcomes in the PEARL study | Kahan, Zsuzsanna; Gil Gil, Miguel; Ruiz Borrego, Manuel; Carrasco, Eva; Ciruelos, Eva; Muñoz Mateu, Montserrat; Bermejo, Begoña; Margeli, Mireia; Antón, Antonio; Casas, Maribel; Csöszi, Tibor; Murillo, Laura; Morales, Serafín; Calvo, Lourdes; Lang, Istvan; Alba, Emilio; Haba Rodriguez, Juan de la; Ramos, Manuel; Álvarez López, Isabel; Gal Yam, Einav; García Palomo, Andrés; Alvarez, Elena; González Santiago, Santiago; Rodríguez, César A.; Servitja, Sonia; Corsaro, Massimo; Rodrigálvarez, Graciela; Zielinski, Christoph; Martín, Miguel |
| 24-Jul-2020 | Immune Cell Associations with Cancer Risk | Palomero, Luis; Galvan Femenia, Ivan; Cid, Rafael de; Espín, Roderic; Barnes, Daniel R.; Blommaert, Eline; Gil Gil, Miguel; Falo Zamora, Catalina; Stradella, Agostina; Ouchi, Dan; Roso Llorach, Albert; Violan, Concepció; Peña Chilet, María; Dopazo, Joaquín; Extremera, Ana I.; Garcia Valero, Mar; Herranz, Carmen; Mateo González, Francesca; Mereu, Elisabetta; Beesley, Jonathan; Chenevix-Trench, Georgia; Roux, Cecilia; Mak, Tak; Brunet, Joan; Hakem, Razq; Gorrini, Chiara; Antoniou, Antonis C.; Lázaro García, Conxi; Pujana Genestar, M. Ángel |
| 1-Aug-2024 | Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer | Di Cosimo, Serena; Pérez García, José Manuel; Bellet Ezquerra, Meritxell; Dalenc, Florence; Gil Gil, Miguel; Ruiz Borrego, Manuel; Gavilá, Joaquín; Aguirre, Elena; Schmid, Peter; Marmé, Frederik; Gligorov, Joseph; Schneeweiss, Andreas; Albanell, Joan; Zamora, Pilar; Wheatley, Duncan; Martínez De Dueñas, Eduardo; Amillano, Kepa; Shimizu, Eileen; Sampayo Cordero, Miguel; Cortés, Javier; Llombart Cussac, Antonio |
| 9-Jul-2021 | Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE Study | Gil Gil, Miguel; Bellet Ezquerra, Meritxell; Bergamino Sirvén, Milana; Morales, Serafín; Barnadas, Agustí; Manso, Luis; Saura, Cristina; Fernández Ortega, Adela; Garcia Martinez, Elena; Martinez Jañez, Noelia; Melé, Mireia; Villagrasa, Patricia; Celiz, Pamela; Perez Martin, X.; Ciruelos, Eva; Pernas, Sònia |
| 9-Oct-2024 | Neoadjuvant sunitinib plus exemestane in post-menopausal women with hormone receptor-positive/HER2-negative early-stage breast cancer (SUT_EXE-08): a phase I/II trial | Fullana, Bartomeu; Morales, Serafín; Petit, Anna; Alay, Ania; Verdaguer, Helena; Climent, Fina; Navarro Perez, Valentí; Cejuela, Mónica; Galvan, Patricia; Gumà, Anna; Llombart Cussac, Antonio; Cordero, David; Casanovas, Oriol; Prat Aparicio, Aleix; Gil Gil, Miguel; Pernas, Sònia |
| Oct-2021 | Organización y Calidad en el ámbito hospitalario | Barba Flores, María Ángeles; Codina Jané, Carles; Corbella, Xavier; Cossio Gil, Yolima; Cuadrado Benet, Sergi; Gamell Àlvarez, Lluís; García Montoya, Encarna; Gil Gil, Miguel; Gil Martin, Marta; González-Muñoz, Esther; Mangues i Bafalluy, Ma. Antònia; Ponce i Sebastià, Jordi; Rovira Lapiedra, Vicky; Sala de Vedruna, Gemma; Salazar Macián, Ramón; Salazar Soler, Albert; Salazar Soler, Ramón; Suñé i Negre, Josep M. (Josep Maria); Tabernero Caturla, Josep; Tomás Martínez, Esther; Vidal Milla, Ángel |
| 1-May-2019 | Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication | Bellet Ezquerra, Meritxell; Ahmad, Faten; Villanueva, Rafael; Valdivia, Carolina; Palomino Doza, Julián; Ruiz, Ada; Gonzalez-Farre, Xavier; Adrover, Encarna; Azaro, Analía; Valls Margarit, Maria; Parra, Josep Lluís; Aguilar Company, Juan; Vidal Losada, Maria Jesús; Martin, Anastasi; Gavilá, Joaquín; Escrivá de Romaní, Santiago; Perelló, Antonia; Hernando, Cristina; Lahuerta, Ainhara; Zamora, Pilar; Reyes, Victoria; Alcalde, María; Masanas, Helena; Celiz, Pamela; Ruiz, Isabel; Gil Gil, Miguel; Seguí, Miquel A.; Peña, Lorena de la |